AORT.NYSEArtivion, INC

4/A: Artivion SVP Marshall S. Stanton Amends Form 4 Filing to Correct Share Reporting

Sentiment:

SEC Filing

📋All filings for Artivion, INC
🔒Login to Follow

Marshall S. Stanton, SVP of Clinical & MD Affairs at Artivion, Inc., filed an amendment to his Form 4 to correct the number of shares beneficially owned following a sell-to-cover transaction.

Summary

  • Marshall S. Stanton, SVP of Clinical & MD Affairs at Artivion, Inc., filed an amended Form 4 with the SEC.
  • The amendment corrects an administrative error in the original filing regarding the number of shares sold in a sell-to-cover transaction on February 26, 2024.
  • The corrected filing reflects an increase in the number of shares reported as beneficially owned.
  • On February 27, 2024, Stanton sold 465 shares of common stock at a price of $19.8344 per share to cover tax withholding obligations upon the vesting of performance stock units.
  • Following the reported transaction, Stanton beneficially owns 81,261 shares of Artivion, Inc.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing (Form 4/A) related to stock transactions by a company insider. The sentiment is neutral as it primarily involves correcting a reporting error.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, ensuring transparency and compliance with SEC regulations.

Key Dates

DateDescription
02/26/2024Date of the original sell to cover transaction with an administrative error in reporting.
02/27/2024Date of the transaction reported in the amended Form 4, involving the sale of 465 shares.
02/29/2024Date of original Form 4 filing.
03/14/2024Date of the amended Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.